These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 9815261)

  • 1. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
    Vance RE; Kraft JR; Altman JD; Jensen PE; Raulet DH
    J Exp Med; 1998 Nov; 188(10):1841-8. PubMed ID: 9815261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition of the class Ib molecule Qa-1(b) by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells.
    Vance RE; Jamieson AM; Raulet DH
    J Exp Med; 1999 Dec; 190(12):1801-12. PubMed ID: 10601355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct binding of purified HLA class I antigens by soluble NKG2/CD94 C-type lectins from natural killer cells.
    Ding Y; Sumitran S; Holgersson J
    Scand J Immunol; 1999 May; 49(5):459-65. PubMed ID: 10320637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells.
    Vance RE; Tanamachi DM; Hanke T; Raulet DH
    Eur J Immunol; 1997 Dec; 27(12):3236-41. PubMed ID: 9464811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
    MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
    FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes.
    Kraft JR; Vance RE; Pohl J; Martin AM; Raulet DH; Jensen PE
    J Exp Med; 2000 Sep; 192(5):613-24. PubMed ID: 10974028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Qa-1b molecule binds to a large subpopulation of murine NK cells.
    Salcedo M; Bousso P; Ljunggren HG; Kourilsky P; Abastado JP
    Eur J Immunol; 1998 Dec; 28(12):4356-61. PubMed ID: 9862372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of murine NKG2A, B and C: second family of C-type lectin receptors on murine NK cells.
    Lohwasser S; Hande P; Mager DL; Takei F
    Eur J Immunol; 1999 Mar; 29(3):755-61. PubMed ID: 10092077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ly49 and CD94/NKG2: developmentally regulated expression and evolution.
    Takei F; McQueen KL; Maeda M; Wilhelm BT; Lohwasser S; Lian RH; Mager DL
    Immunol Rev; 2001 Jun; 181():90-103. PubMed ID: 11513155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
    Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
    J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of a gene in the rat homologous to human CD94.
    Dissen E; Berg SF; Westgaard IH; Fossum S
    Eur J Immunol; 1997 Aug; 27(8):2080-6. PubMed ID: 9295048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the molecular factors controlling Qa1-mediated protection of target cells from NK lysis.
    Gays F; Fraser KP; Toomey JA; Diamond AG; Millrain MM; Dyson PJ; Brooks CG
    J Immunol; 2001 Feb; 166(3):1601-10. PubMed ID: 11160201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal analysis of NK cell development from bone marrow progenitors in vitro: orderly acquisition of receptor gene expression.
    Williams NS; Kubota A; Bennett M; Kumar V; Takei F
    Eur J Immunol; 2000 Jul; 30(7):2074-82. PubMed ID: 10940897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.